Combination of Olutasidenib and Azacitidine Induces Durable Complete Remissions in mIDH1 Acute Myeloid Leukemia: A Multicohort Open-Label Phase 1/2 Trial ... in US Military Service Members: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback